Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blanchet

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Development (Cambridge, England)|April 19, 2003
Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neuronsPepijn van den Munckhof, Kelvin C Luk, Line Ste-Marie, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Frontiers in Neurology|April 11, 2019
Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily LivingEtienne Goubault, Hung P Nguyen, Sarah Bogard, et al.
Experimental Brain Research|October 25, 2007
Sensorimotor adaptation in Parkinson's disease: evidence for a dopamine dependent remapping disturbanceF Paquet, M A Bedard, M Levesque, et al.
Synapse (New York, N.Y.)|April 17, 2001
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporterF Calon, N Lavertu, A M Lemieux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2020
Chronic Neuroleptic-Induced Parkinsonism Examined With Positron Emission TomographyManon Galoppin, Pierre Berroir, Jean-Paul Soucy, et al.
Journal of Oral & Facial Pain and Headache|October 30, 2016
Characterization of Burning Mouth Syndrome in Patients with Parkinson's DiseaseDavid Bonenfant, Pierre H Rompré, Nathalie Rei, et al.
Parkinsonism & Related Disorders|June 16, 2004
Relevance of the MPTP primate model in the study of dyskinesia priming mechanismsPierre J Blanchet, Frédéric Calon, Marc Morissette, et al.
Trends in Neurosciences|October 29, 2000
Dopamine-receptor stimulation: biobehavioral and biochemical consequencesF Calon, A Hadj Tahar, P J Blanchet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Pathophysiology of L-dopa-induced dyskinesiasP J Bédard, P J Blanchet, D Lévesque, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Development (Cambridge, England)|April 19, 2003
Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neuronsPepijn van den Munckhof, Kelvin C Luk, Line Ste-Marie, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeysP J Blanchet, F Calon, J C Martel, et al.
Frontiers in Neurology|April 11, 2019
Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily LivingEtienne Goubault, Hung P Nguyen, Sarah Bogard, et al.
Experimental Brain Research|October 25, 2007
Sensorimotor adaptation in Parkinson's disease: evidence for a dopamine dependent remapping disturbanceF Paquet, M A Bedard, M Levesque, et al.
Synapse (New York, N.Y.)|April 17, 2001
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporterF Calon, N Lavertu, A M Lemieux, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2020
Chronic Neuroleptic-Induced Parkinsonism Examined With Positron Emission TomographyManon Galoppin, Pierre Berroir, Jean-Paul Soucy, et al.
Journal of Oral & Facial Pain and Headache|October 30, 2016
Characterization of Burning Mouth Syndrome in Patients with Parkinson's DiseaseDavid Bonenfant, Pierre H Rompré, Nathalie Rei, et al.
Parkinsonism & Related Disorders|June 16, 2004
Relevance of the MPTP primate model in the study of dyskinesia priming mechanismsPierre J Blanchet, Frédéric Calon, Marc Morissette, et al.
Trends in Neurosciences|October 29, 2000
Dopamine-receptor stimulation: biobehavioral and biochemical consequencesF Calon, A Hadj Tahar, P J Blanchet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Pathophysiology of L-dopa-induced dyskinesiasP J Bédard, P J Blanchet, D Lévesque, et al.
Pageof 11